Design Variants:1. Observatory2. The Journal3. Clinical4. DNA Blueprint5. Perfusion Flow6. Biomedical AI7. Greenhouse8. Lavender Mist9. Slate & Teal10. Aurora

Use Cases

Use Cases for Revalia Studies

Revalia Bio's studies are designed to support multiple stakeholders across the life sciences ecosystem.

Trusted by Industry Leaders

Since the beginning, we have been delivering critical insights to industry leaders, including:

  • Two of the world’s top 10 pharmaceutical companies
  • Prestigious academic healthcare systems
  • Established organ procurement partnerships

Use Cases: Revalia Improves Program Confidence

Below are representative examples of how different types of organizations apply organ-level human insight prior to clinical testing.

Pharma

Reducing Translational Risk Before First-in-Human Studies

A pharmaceutical company is developing a targeted oncology therapy and needs to understand distribution, toxicity, and tissue response in human biology prior to IND submission.

How Revalia Helps

  • Conduct organ-level toxicity assessment with human tissue
  • Evaluate drug delivery and distribution using clinical-grade imaging
  • Generate data to inform dosing and safety strategy
Outcome

Stronger confidence entering clinical trials, reduced downstream uncertainty, and better preparation for regulatory discussions.

Explore Pharma Development
Biotech

De-Risking Novel Therapeutics Early

A biotech company is advancing a novel therapeutic platform but lacks scalable human-relevant models to validate the mechanism of action, tissue response, and safety prior to IND submission.

How Revalia Helps

  • Organ-level functional testing in perfused human organs
  • Mechanistic insight in disease-relevant human tissue
  • Structured data to inform dosing and translational strategy
Outcome

Earlier clarity on asset viability, more confident next-step decision-making, and reduced downstream development risk.

Explore Biotech Solutions
Medical Device

Validating Performance in Human Tissue

A medical device company must evaluate delivery, performance, and tissue interaction in human biology prior to clinical evaluation.

How Revalia Helps

  • Image-guided delivery studies in revived human organs
  • Functional performance assessment in real human tissue
  • Organ-level insight prior to first-in-human studies
Outcome

Stronger preclinical validation, clearer regulatory positioning, and increased confidence before clinical trials.

Explore Device Validation
Pharma

Understanding Drug Delivery Variability in Human Tumors

A pharmaceutical company developing a targeted oncology therapy observed inconsistent responses among patients. Researchers suspected that tumor biology might be influencing drug delivery but lacked a human-relevant model to investigate the issue.

How Revalia Helps

  • Evaluate drug penetration and distribution in perfused human tumor tissue
  • Analyze how tumor density and structure influence therapeutic delivery
  • Generate organ-level biological data to understand variability in therapeutic response
Outcome

Tumor density was identified as a key factor influencing drug penetration, helping explain differences in patient response and providing greater clarity on drug delivery dynamics for future development decisions.

Learn About Oncology Studies
Academic Medical Centers

Participating in the Human Data Infrastructure

An academic health system seeks to strengthen institutional leadership in human-centered science while maintaining governance integrity.

How Revalia Helps

  • Establish research-governed infrastructure aligned with existing clinical workflows
  • Integrate organ donation programs into scalable research models
  • Enable investigator-driven organ-level studies
Outcome

Institutionally governed participation in a scalable human data infrastructure without disrupting clinical care.

Download Our 1-Pager
“

I've been chasing this type of opportunity for ~8 years. The challenge has been the infrastructure to facilitate research donor organs paired with having the folks skilled to perform the experiments on short notice. The team at Revalia has addressed these challenges and have opened the door for some incredible research opportunities.

— Revalia Customer, Top 10 Pharma Company

Bridge the gap between biology and breakthrough

Ready to accelerate your next program? Schedule a meeting with our team to explore how Human Data Trials can transform your pipeline.

Schedule a MeetingLearn How It Works